Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026

FY2025 EPS improved to ($0.08) compared to ($0.50) in FY2024 YoY net loss reduced 76% to ($896K) from ($3.8M) in FY2024 Population health revenue grew 157% to $5.3 million versus $2.1 million in FY2024 Operating expenses declined 37% to $3.4 million compared to $5.4 million in FY2024 CARMEL, Ind., March 12, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the fourth quarter and full year ended December 31, 2025.